Analystreport

Rocket Pharmaceuticals Inc (NASDAQ: RCKT) was given a new $39.00 price target on by analysts at Oppenheimer Holdings Inc.. They now have a "buy" rating on the stock.

Rocket Pharmaceuticals, Inc.  (RCKT) 
Last rocket pharmaceuticals, inc. earnings: 3/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: rocketpharma.com